Startale launches Soneium-integrated SuperApp for seamless Web3 access, early airdrops, on-chain rewards, and simplified blockchain utility for global users.Startale launches Soneium-integrated SuperApp for seamless Web3 access, early airdrops, on-chain rewards, and simplified blockchain utility for global users.

Startale Debuts Soneium-Integrated SuperApp for Seamless Web3 Accessibility and Exclusive Airdrops

zk rollup app chains forart

Startale Group, a Tokyo-based Web3 infrastructure platform, has partnered with Soneium, an Ethereum-built public L2 blockchain. As included in this collaboration, Startale has launched Startale App, a cutting-edge Web3 SuperApp to offer an inclusive gateway to enter the Soneium ecosystem. As per Startale’s official press release, the app links directly to the $75B DeFi network of Ethereum. Hence, the consumers can access token generation events (TGEs), on-chain rewards, and ecosystem airdrops early.

Startale and Soneium to Expand Web3 Access with Simplified User Experience

In partnership with Soneium, Startale is introducing Startale App as a SupperApp for a unified user experience with early access for on-chain rewards, TGEs, and airdrops. Developed on the L2 framework of Ethereum, the app places Startale as a notable player in worldwide SuperApp race.

Additionally, Soneium has surged above 380M transfers across over 5.1M wallets, with selected projects offering unique experiences and rewards via the Startale App. While discussing this move, the Startale Group CEO, Sota Watanable, asserted that the app further improves usability via Mini Apps. He stated,

 “Startale App was designed to remove the final barrier to Web3 adoption, the fragmented user experience.Through our longstanding partnership with Sony and Soneium, we’ve built a platform that makes going onchain as intuitive as opening any mainstream app, while ensuring interoperability across Ethereum and ecosystems worldwide, including Japan’s regulated digital asset ecosystem.”

Unifying Mainstream Finance and Blockchain for Global Adoption

According to Startale, the launch of Startale App in collaboration with Soneium aligns with its goal to merge mainstream finance with blockchain technology. Additionally, the platform has recently collaborated with SBI Holdings in a move to delve into stablecoin infrastructure to provide a 24/7 blockchain-driven trading entity. Ultimately, the new launch unifies the infrastructure that simplifies Web3 to bring numerous new users on-chain.

This SuperApp permits builders to develop on Soneium while requiring no standalone websites.  Sota Watanable believes that this initiative attempts to eliminate the final barrier of fragmented consumer experience to streamline Web3 adoption. Thus, amid the growing Web3 super-app sector, Startale’s endeavor underscores a strategic development to combine seamless client experience with wider blockchain access in the mainstream.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26